Clinical trial
Zithromax EV in Community-Acquired Pneumonia (CAP)
NCT00137007 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00137007 |
|---|---|
| Title | Zithromax EV in Community-Acquired Pneumonia (CAP) |
| Official title | A Multicenter, Open Label Trial Evaluating Intravenous Azithromycin Plus Intravenous Ampicillin/Sulbactam Followed by Oral Azithromycin Plus Intravenous Ampicillin/Sulbactam for the Treatment of Hospitalized Subjects With Community-Acquired Pneumonia (CAP) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | Azithromycin, Ampicillin/sulbactam |
| Enrollment | 151 |
| Start date | Nov 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Aug 29, 2005 |
| Last update posted | Apr 22, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: